Showing results (1471-1480 of 4,565) with videos related to

Sort By:
Pageof 457
Advances in Therapy|July 16, 2005
Lipid-lowering effect of 2 dosages of a soy protein supplement in hypercholesterolemiaLars H Høie, Hans-Joachim Graubaum, Andrea Harde, et al.
Advances in Therapy|December 4, 2022
The MODIFY Study Protocol: An Open-Label, Single-Arm, Multicenter, Prospective Pragmatic Study of Ixazomib-Based Triple-Drug Therapy in Chinese Patients with Multiple MyelomaWenming Chen, Aijun Liu, Lin Li
Advances in Therapy|June 8, 2021
Cost-Effectiveness of Nivolumab Plus Ipilimumab Combined with Two Cycles of Chemotherapy as First-Line Treatment in Advanced Non-Small Cell Lung CancerYe Peng, Xiaohui Zeng, Liubao Peng, et al.
Advances in Therapy|June 8, 2022
Estimating the Prevalence of Rare Diseases: Long-Chain Fatty Acid Oxidation Disorders as an Illustrative ExampleEliza Kruger, Paul McNiven, Deborah Marsden
Advances in Therapy|June 9, 2022
Budget Impact and Cost-Effectiveness of Intravenous Meloxicam to Treat Moderate-Severe Postoperative PainJohn A Carter, Libby K Black, Kathleen L Deering, et al.
Advances in Therapy|June 9, 2022
Comparative Efficacy of Brolucizumab in the Treatment of Neovascular Age-Related Macular Degeneration: A Systematic Literature Review and Network Meta-AnalysisRobert P Finger, Natalie Dennis, Rita Freitas, et al.
Advances in Therapy|June 10, 2022
Improved Prediction of Body Mass Index in Real-World Administrative Healthcare Claims DatabasesGanhui Lan, Bingcao Wu, Kaustubh Sharma, et al.
Advances in Therapy|November 24, 2022
Economic Impact of Transformation to Acute Myeloid Leukemia Among Actively Managed Patients with Higher-Risk Myelodysplastic Syndromes in the United StatesVamsi Kota, Augustina Ogbonnaya, Eileen Farrelly, et al.
Advances in Therapy|July 7, 2022
Efficacy and Safety of Ultrafiltration in Patients with Heart Failure: A Single-Center ExperienceShen Xiangli, Li Lan, Zu Libiya, et al.
Advances in Therapy|January 6, 2023
Population Pharmacokinetics of CMAB008 (an Infliximab Biosimilar) and Remicade® in Healthy Subjects and Patients with Moderately to Severely Active Rheumatoid ArthritisYin Su, Jing Li, Chenguang Wang, et al.
Pageof 457